Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
10/1991
10/02/1991CN1055009A Production of human basic fgf-mutein
10/01/1991WO1991015223A1 Respiratory burst suppression factor
10/01/1991US5053454 Multiple polymer synthesizer
10/01/1991US5053326 Hybridization method and probe
10/01/1991CA2055593A1 Respiratory burst suppression factor
10/01/1991CA2027447A1 Glycosaminoglycan-modified protein
09/1991
09/27/1991CA2037204A1 Method for purification of monoclonal antibodies
09/26/1991DE4008852A1 Verfahren zur herstellung von nicht-infektioesem blutplasma A process for producing non-infectious blood plasma
09/25/1991EP0448513A2 Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof
09/25/1991EP0448353A2 Lipopeptide compounds
09/25/1991EP0448181A2 Interleukin-6 inhibiting compositions
09/25/1991EP0448075A1 Immunoglobulin G and process for the production thereof
09/25/1991EP0447746A1 A method for separating Diphenylurea(DPU) and phenylthiohydantoin-tryptophan (PTH-TRP) allowing unambiguous indentification of TRP in automatic sequence analysis
09/25/1991EP0447547A1 C-terminus amidation enzyme composition, process for its preparation and its use
09/25/1991EP0447476A1 New tnf peptides
09/25/1991EP0447474A1 New tnf peptides
09/25/1991EP0447472A1 New tnf peptides
09/25/1991EP0447465A1 New tnf peptides
09/25/1991EP0447435A1 Novel tnf peptides
09/25/1991EP0447432A1 New tnf peptides
09/25/1991EP0447431A1 New tnf peptides
09/25/1991EP0447430A1 New tnf peptides
09/25/1991EP0447429A1 New tnf peptides
09/25/1991EP0420964A4 Lyophilized peptide formulations
09/25/1991CN1054773A Hemoregulatory peptides
09/25/1991CN1054772A Synthetic polypeptides
09/24/1991US5051526 Reagents for solid phase synthesis of polypeptides
09/24/1991US5051497 Dissolving a protein by contacting with an ion exchanger and separation by use of denaturing agent
09/24/1991US5051404 Tripeptide compounds having hypotensive activity
09/24/1991US5051368 Reaction of N-protected amino acid with N-substituted ketenimine to form an activated ester followed by reaction with thiocarbonyl group
09/24/1991CA2038911A1 Catalytic antibody components
09/24/1991CA1289474C Antibodies useable as pilot agents, and compounds containing same
09/22/1991CA2038569A1 Process for production of peptidylglycine ó-hydroxylating monooxygenase and use thereof
09/20/1991CA2038525A1 Lipopeptide compounds
09/19/1991WO1991013985A1 Leukaemia inhibitory factor
09/19/1991WO1991013983A1 DNA SEQUENCE ENCODING GALACTOPROTEIN b3
09/19/1991WO1991013861A1 Method for preparing n-protected (2s,3s)-3-ethylaspartic acid dialkyl esters
09/19/1991WO1991013631A1 Method for enhancing antibody transport through capillary barriers
09/18/1991EP0447322A2 A process for preparing a purified Treponemal antigen and use thereof
09/18/1991EP0447143A2 Carrier for biochemically active substances
09/18/1991EP0446876A2 Secretory component-containing composition
09/18/1991EP0446797A2 Synthetic peptides containing factor VIIa sequences and their use
09/18/1991EP0446763A2 Antigen for producing anti-idiotype antibody, anti-idiotype antibody and method for producing the anti-idiotype antibody
09/18/1991EP0446706A2 Peptides with tachykinin-agonistic or -antagonistic activity
09/18/1991EP0446485A2 Peptide analogues with renininhibiting activity
09/18/1991EP0446299A1 Method for site-specifically incorporating unnatural amino acids into proteins
09/18/1991EP0446272A1 EXPRESSION OF HIV PROTEINS IN $i(DROSOPHILA) CELLS
09/17/1991US5049684 Electrically conducting material and process of preparing same
09/17/1991US5049668 Antitumor
09/17/1991US5049658 Polypeptide with cell-spreading activity
09/17/1991US5049656 Capping
09/17/1991US5049545 Insulin derivatives, a process for their preparation, and their use
09/17/1991US5049507 Method of C-terminal peptide sequencing
09/17/1991US5049506 Proline-containing decapeptides as substrates for factor XIII
09/16/1991WO1991013909A1 Synthetic polypeptides
09/16/1991CA2078220A1 Synthetic polypeptides
09/15/1991WO1991013891A1 Acyl phosphate esters and modification of proteins therewith
09/14/1991CA2037990A1 Amino acid derivatives
09/14/1991CA2037772A1 Method for separating diphenylurea (dpu) and phenylthiohydantoin-tryptophan (pth-trp) allowing unambiguous identification of trp in automatic sequence analysis
09/11/1991EP0446071A2 Tris-maleimido compounds as intermediates in trifunctional antibody synthesis
09/11/1991EP0445915A1 Method of performing a multiple synthesis of peptides on a solid carrier and apparatus for carrying out this method
09/11/1991EP0445896A2 Bacterial produced extracts and enzymes for cleavage of organic C-S bonds
09/11/1991EP0445681A2 Preparation of a thrombin-binding substance
09/11/1991EP0445467A1 Renin inhibitors and antiviral agents
09/11/1991EP0445227A1 Position-specific insertion vectors and method of using same
09/11/1991EP0441871A4 A sheet feeding apparatus
09/11/1991EP0188479B1 Lymphokine production and purification
09/10/1991WO1991013906A1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION
09/10/1991US5047573 Process for the production of peptides using diacylamines
09/10/1991US5047513 Nickel nitrilotriacetates bound to a matrix-spacer system to purify proteins and peptides having surface histidine residues; chromatography
09/10/1991US5047511 Method for recovering recombinant proteins
09/10/1991US5047506 Method for the purification of factor XIII by affinity chromatography
09/10/1991US5047400 Treatment of infection; antitumor agents
09/10/1991US5047333 Method for the preparation of natural human growth hormone in pure form
09/10/1991US5047257 Sprout-damaged wheat flour containing barley alpha-amylase inhibitor
09/10/1991CA2037811A1 Tris-maleimido compounds as intermediates in trifunctional antibody synthesis
09/10/1991CA1288896C Immunoglobulin conjugates
09/08/1991WO1991013907A1 Derivatives of n-phenyl glycinamide, their preparation and medicaments containing them
09/08/1991CA2074375A1 N-phenyl glycinamide derivatives, preparation thereof and drugs containing same
09/07/1991CA2037499A1 Preparation of a thrombin-binding substance
09/06/1991WO1991013904A1 Chymotrypsin-like proteases and their inhibitors
09/06/1991CA2077665A1 Chymotrypsin-like proteases and their inhibitors
09/05/1991WO1991013098A1 Solid supports for use in solid-phase biosystems
09/05/1991WO1991013097A1 Polyaminocarboxylic acid derivatives
09/05/1991WO1991013094A1 Inhibitor of proliferation of endothelial cells
09/05/1991WO1991012886A1 Immobilized polyethylene oxide star molecules for bioapplications
09/05/1991WO1991012812A1 Inhibitors of catalytic antibodies
09/05/1991WO1991012730A2 Recovery of protein, protein isolate and/or starch from cereal grains
09/05/1991DE4006349A1 Solid phase peptide synthesis on floating carrier - by mixing solvents of differing densities so that the carrier is homogeneously dispersed without floating or precipitating
09/04/1991EP0444897A1 Novel immunosuppressive cyclosporin analogs with modified amino acids at position-8
09/04/1991EP0444605A2 Angiotensin converting enzyme inhibitor, method for preparing it, composition containing the same and use thereof
09/04/1991EP0444560A1 Antibody specific for the tumor necrosis factor receptor
09/04/1991EP0444158A1 Conjugated polypeptides and methods for their preparation and use.
09/04/1991EP0444129A1 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use
09/04/1991EP0444111A1 Enzyme stabilisation
09/04/1991EP0444068A1 Trialkysilyl esters of amino acids and their use in the synthesis of peptides
09/03/1991WO1991013166A1 Antibody constructs with enhanced binding affinity
09/03/1991WO1991013087A1 Hybrid compound purification
09/03/1991WO1991012819A1 Improved immunogenic compositions
09/03/1991US5045631 Polypeptides with cell-spreading activity